Coronavirus Facts and Myth Buster
With inputs from Dr Monica Vasudev US FDA cautions about antibody tests to assess immunity among the vaccinated In a safety communication, the US FDA …Read more
Month: May 2021
World COVID Meter 30th May 2021: Acute manageable immunogenic thrombogenic inflammatory contagious novel viral disease pandemic
CMAAO: In susceptible high-risk (pro-inflammatory and/or pro-coagulative) individuals, reactogenic vaccines can trigger transient thrombo-inflammation lasting first few (up to four) days. COVID Vaccine: non-replicative, non-repetitive …Read more
Sotrovimab, the latest addition to the anti-COVID-19 armamentarium
Sotrovimab, a monoclonal antibody has been accorded emergency use authorisation (EUA) by the US FDA for use in patients aged 12 years and older with …Read more
World COVID Meter 29th May 2021: Acute manageable immunogenic thrombogenic inflammatory contagious novel viral disease pandemic
CMAAO: In susceptible high-risk (pro-inflammatory and/or pro-coagulative) individuals, reactogenic vaccines can trigger transient thrombo-inflammation lasting first few (up to four) days. COVID Vaccine: non-replicative, non-repetitive …Read more
Keep diabetes under control to prevent mucormycosis in Covid-19 patients
A systematic review was conducted to analyse the characteristics of patients with Covid-19 infection, who also had developed mucormycosis, and their outcomes. This review also …Read more
World COVID Meter 28th May 2021: Acute manageable immunogenic thrombogenic inflammatory contagious novel viral disease pandemic
CMAAO: In susceptible high-risk (pro-inflammatory and/or pro-coagulative) individuals, reactogenic vaccines can trigger transient thrombo-inflammation lasting first few (up to four) days. COVID Vaccine: non-replicative, non-repetitive …Read more
Ischemic stroke can be indicative of vaccine-induced thrombosis and thrombocytopenia
Stroke due to cerebral sinus thrombosis as a presenting feature of vaccine-induced thrombosis and thrombocytopenia (VITT) has been frequently reported earlier. However, ischemic stroke due …Read more
World COVID Meter 27th May 2021: Acute manageable immunogenic thrombogenic inflammatory contagious novel viral disease pandemic
CMAAO: In susceptible high-risk (pro-inflammatory and/or pro-coagulative) individuals, reactogenic vaccines can trigger transient thrombo-inflammation lasting first few (up to four) days. COVID Vaccine: non-replicative, non-repetitive …Read more
Take both doses of Covid vaccine to get maximum protection against B.1.617 variant
Pfizer and AstraZeneca Covid-19 vaccines are effective against symptomatic disease due to the B.1.617.2 variant detected in India, according to a new study conducted by …Read more
World COVID Meter 26th May 2021: Acute manageable immunogenic thrombogenic inflammatory contagious novel viral disease pandemic
CMAAO: In susceptible high-risk (pro-inflammatory and/or pro-coagulative) individuals, reactogenic vaccines can trigger transient thrombo-inflammation lasting first few (up to four) days. COVID Vaccine: non-replicative, non-repetitive …Read more